You are here

Vascepa

Amarin Posts New Data Showing Benefit of Vascepa In High-Risk Patients With Acute Coronary Syndrome

Yahoo/Benzinga

Tue, 03/7/23 - 10:16 am

acute coronary syndrome

clinical trials

In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics

Fierce Pharma

Fri, 02/24/23 - 08:55 am

Struggling Amarin jousts with activist investor Sarissa as board vote nears

Fierce Pharma

Tue, 02/14/23 - 10:44 am

Why Amarin Stock Was a Winner Today

Motley Fool

Tue, 11/15/22 - 06:38 pm

Amarin stands behind Vascepa after new analysis raises questions about its efficacy

Fierce Pharma

Tue, 07/5/22 - 12:04 am

Amarin turns to job cuts as generics challenge its heart pill

BioPharma Dive

Tue, 06/7/22 - 10:18 am

With sales sagging, Amarin sees progress on new Vascepa digital effort in the US

Fierce Pharma

Wed, 03/2/22 - 09:55 am

digital marketing

Faced with generic rivals, Amarin cuts 400-plus sales reps as part of revamped Vascepa strategy

Fierce Pharma

Thu, 09/23/21 - 10:29 pm

ESC: Amarin touts Vascepa's ability to reduce repeat heart problems as it fights generic with 'skinny label' claim

Fierce Pharma

Mon, 08/23/21 - 11:32 pm

Amarin's Vascepa patent defense ends in a loss at the Supreme Court

Fierce Pharma

Mon, 06/21/21 - 10:09 pm

Amarin launches Vascepa in all-important Europe as it slowly bleeds share to U.S. generic

Fierce Pharma

Tue, 04/6/21 - 11:02 pm

The top 10 drugs losing U.S. exclusivity in 2021

Fierce Pharma

Wed, 03/10/21 - 10:59 pm

Amarin vs. the Generics: Who Will Win?

Motley Fool

Sun, 11/22/20 - 11:55 pm

AHA: Amarin's Vascepa cuts cardiovascular events in patients with coronary artery grafts

Fierce Pharma

Mon, 11/16/20 - 10:33 pm

Amarin loses patent appeal and their brief grip on a cardiovascular, fish oil empire

Endpoints

Fri, 09/4/20 - 12:04 am

Amarin Patent Appeal Is a Coin Toss With Billions on the Line

Yahoo/Bloomberg

Wed, 09/2/20 - 11:07 am

ESC: Amarin's Vascepa reduces patients' arterial plaque after 18 months of treatment

Fierce Pharma

Sun, 08/30/20 - 11:26 pm

arterial plaque

Amarin spurns would-be marketing partners to launch Vascepa in Europe on its own

Fierce Pharma

Tue, 08/4/20 - 12:38 pm

Here's Why Amarin Tumbled 67.7% in the First Half of 2020

Motley Fool

Thu, 07/9/20 - 12:02 am

A new hope for Amarin? Vascepa generic settlement leaves analysts split on patent appeal success

Fierce Pharma

Wed, 06/17/20 - 10:20 pm

Pages